Paper39768384
Pilot Study on the Effects of a Cosmetic Serum Containing Niacinamide, Postbiotics and Peptides on Facial Skin in Healthy Participants: A Randomized Controlled Trial.
Rusic D and 9 others. Life (Basel), 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Pilot Study on the Effects of a Cosmetic Serum Containing Niacinamide, Postbiotics and Peptides on Facial Skin in Healthy Participants: A Randomized Controlled Trial. Papers, record 39768384. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39768384
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pilot Study on the Effects of a Cosmetic Serum Containing Niacinamide, Postbiotics and Peptides on Facial Skin in Healthy Participants: A Randomized Controlled Trial.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT06189105 | Efficacy and Safety Assessment of Niacinamide Cosmetic Preparation: a Randomized Controlled Trial | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT07433907 | Efficacy of an Antioxidant Moisturizing Serum for Mild to Moderate Seborrheic Dermatitis | Background | ClinicalTrials.gov |
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36693604 | Preparation of niacinamide imprinted starch-based biomaterials for treating of hyperpigmentation. | Int J Biol Macromol | 2023 | https://conductscience.org/library/papers/36693604 | PubMed |
| 2 | 37489567 | Skin Cancer Prevention across the G7, Australia and New Zealand: A Review of Legislation and Guidelines. | Curr Oncol | 2023 | https://conductscience.org/library/papers/37489567 | PubMed |
| 3 | 25645051 | Skin colour, skin redness and melanin biometric measurements: comparison study between Antera(®) 3D, Mexameter(®) and Colorimeter(®). | Skin Res Technol | 2015 | https://conductscience.org/library/papers/25645051 | PubMed |
| 4 | 38136732 | Innovative Approaches for Maintaining and Enhancing Skin Health and Managing Skin Diseases through Microbiome-Targeted Strategies. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/38136732 | PubMed |
| 5 | 35741330 | Sphingosine 1-Phosphate Signaling at the Skin Barrier Interface. | Biology (Basel) | 2022 | https://conductscience.org/library/papers/35741330 | PubMed |
| 6 | 26916232 | The role of topical dermocosmetics in acne vulgaris. | J Eur Acad Dermatol Venereol | 2016 | https://conductscience.org/library/papers/26916232 | PubMed |
| 7 | 34148998 | Defining Skin Quality: Clinical Relevance, Terminology, and Assessment. | Dermatol Surg | 2021 | https://conductscience.org/library/papers/34148998 | PubMed |
| 8 | 27142709 | Cosmeceuticals: peptides, proteins, and growth factors. | J Cosmet Dermatol | 2016 | https://conductscience.org/library/papers/27142709 | PubMed |
| 9 | 37568569 | Assessing Skin Cancer Risk Factors, Sun Safety Behaviors and Melanoma Concern in Atlantic Canada: A Comprehensive Survey Study. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37568569 | PubMed |
| 10 | 31835478 | Topical Delivery of Niacinamide: Influence of Binary and Ternary Solvent Systems. | Pharmaceutics | 2019 | https://conductscience.org/library/papers/31835478 | PubMed |
| 11 | 30698874 | Nicotinamide for photoprotection and skin cancer chemoprevention: A review of efficacy and safety. | Exp Dermatol | 2019 | https://conductscience.org/library/papers/30698874 | PubMed |
| 12 | 35337168 | Up-to-Date Overview of the Use of Natural Ingredients in Sunscreens. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/35337168 | PubMed |
| 13 | 34834383 | Topical Delivery of Niacinamide to Skin Using Hybrid Nanogels Enhances Photoprotection Effect. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34834383 | PubMed |
| 14 | 37113085 | In vivo transepidermal water loss: Validation of a new multi-sensor open chamber water evaporation system Tewameter TM Hex. | Skin Res Technol | 2023 | https://conductscience.org/library/papers/37113085 | PubMed |
| 15 | 35209068 | A Mixture of Topical Forms of Polydeoxyribonucleotide, Vitamin C, and Niacinamide Attenuated Skin Pigmentation and Increased Skin Elasticity by Modulating Nuclear Factor Erythroid 2-like 2. | Molecules | 2022 | https://conductscience.org/library/papers/35209068 | PubMed |
| 16 | 34804354 | Clinical Comparison of Topical 2.5% Benzoyl Peroxide plus 5% Niacinamide to 2.5% Benzoyl Peroxide Alone in the Treatment of Mild to Moderate Facial Acne Vulgaris. | J Clin Aesthet Dermatol | 2021 | https://conductscience.org/library/papers/34804354 | PubMed |
| 17 | 31709535 | Skin barrier immunity and ageing. | Immunology | 2020 | https://conductscience.org/library/papers/31709535 | PubMed |
| 18 | 38299457 | Efficacy of ceramides and niacinamide-containing moisturizer versus hydrophilic cream in combination with topical anti-acne treatment in mild to moderate acne vulgaris: A split face, double-blinded, randomized controlled trial. | J Cosmet Dermatol | 2024 | https://conductscience.org/library/papers/38299457 | PubMed |
| 19 | 37374920 | Oral and Topical Probiotics and Postbiotics in Skincare and Dermatological Therapy: A Concise Review. | Microorganisms | 2023 | https://conductscience.org/library/papers/37374920 | PubMed |
| 20 | 23914212 | Comparison of topical 5% nicotinamid gel versus 2% clindamycin gel in the treatment of the mild-moderate acne vulgaris: A double-blinded randomized clinical trial. | J Res Med Sci | 2013 | https://conductscience.org/library/papers/23914212 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794388 | Development of Pharmabiotic Gel-Serums with Lacticaseibacillus casei Postbiotics and Paraprobiotics Using Chitosan and Carbopol. | Gels | 2026 | https://conductscience.org/library/papers/42794388 | PubMed |
| 41302077 | Integration of Postbiotics into Adult Diapers: In Vitro Evaluation of Biocompatibility and Effect on Skin Microbiota. | Life (Basel) | 2025 | https://conductscience.org/library/papers/41302077 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39768384
GET https://conductscience.org/api/papers/v1/39768384/references?page=2